Actos Needs Stronger Cancer Warnings: EU Regulator
European health regulators said Thursday that Takeda Pharmaceutical Co. Ltd.'s diabetes drug Actos — which has been banned in France and Germany — remains a valid treatment option, but should come...To view the full article, register now.
Already a subscriber? Click here to view full article